Navigation Sciences is developing the NaviSci system, which tracks a small lung tumour in real time during keyhole surgery so the surgeon can remove it with a safe margin. It is an investigational device.
Navigation Sciences, Inc. is developing the NaviSci system to locate and remove soft tissue cancers, starting with small lung nodules; the company says the system has completed a clinical feasibility trial and labels it an investigational device. The NIH RePORTER abstract describes real-time navigation to localise non-palpable nodules and resect them with sufficient margins during sublobar resection such as segmentectomy. In fiscal year 2026 NCI awarded it USD 181,271 under STTR award 5R41CA306611-02.
Investors not recorded; see the round sources.
| Round | Year | Amount | Source |
|---|---|---|---|
| Grant · NCI STTR award (R41) 5R41CA306611-02: Targeted Localization and Optimized Surgical Resection for Lung Cancer | 2026 | $181K | reporter.nih.gov |
Amounts only where the cited source states them. Rounds without a public source are not listed.
The NaviSci system is an investigational surgical navigation device from Navigation Sciences that helps surgeons find and remove small lung tumours with a clear margin.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/